There were 15 press releases posted in the last 24 hours and 154,951 in the last 365 days.
For Immediate Release: May 24, 2019 Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone …
For Immediate Release: May 24, 2019 The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), the most …
For Immediate Release: May 23, 2019 Today, the U.S. Food and Drug Administration permitted marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint infection (infection around a joint replacement) in the …
For Immediate Release: May 23, 2019 The U.S. Food and Drug Administration is alerting hospitals, laboratories and providers of a Class 1 recall of Beckman Coulter DxH 800, DxH 600 and DxH 900 hematology analyzers—devices that run blood tests to help …
For Immediate Release: May 23, 2019 Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood. The ZIKV Detect 2.0 IgM Capture ELISA is the first Zika …
FDA News Release FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea For Immediate Release: May 23, 2019 Today, the U.S. Food and Drug Administration cleared for marketing two tests that can detect the presence of the …
For Immediate Release: May 22, 2019 U.S. District Judge Virginia M. Kendall for the Northern District of Illinois entered a consent decree of permanent injunction today between the United States and PharMedium Services, LLC, headquartered in Lake Forest, …
For Immediate Release: May 22, 2019 U.S. District Judge Keith P. Ellison for the Southern District of Texas signed and entered a consent decree of permanent injunction, ordering a Texas-based company and its owners to stop producing compounded drugs …
For Immediate Release: May 17, 2019 Today, the U.S. Food and Drug Administration is warning patients and health care professionals of risks associated with the use of unapproved or unauthorized devices for diabetes management, including continuous glucose …
For Immediate Release: May 16, 2019 The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients one month of …
For Immediate Release: May 14, 2019 The U.S. Food and Drug Administration has posted warning letters to five companies who produce products labeled as homeopathic for significant violations of current good manufacturing practice (CGMP) regulations. Four of …
For Immediate Release: April 03, 2019 Statement From: Statement Author Leadership Role Leadership Role Commissioner of Food and Drugs - Food and Drug Administration Scott Gottlieb M.D. Leadership Role Leadership Role Principal Deputy Commissioner - Office …
For Immediate Release: May 10, 2019 Statement From: Statement Author Leadership Role Leadership Role Commissioner of Food and Drugs - Food and Drug Administration Norman E. "Ned" Sharpless MD The U.S. Food and Drug Administration plays an …
For Immediate Release: May 06, 2019 On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused by transthyretin mediated …
For Immediate Release: May 06, 2019 The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age. This is the first FDA …
For Immediate Release: May 08, 2019 Statement From: Statement Author Leadership Role Leadership Role Principal Deputy Commissioner - Office of the Commissioner Amy Abernethy MD PhD. Leadership Role Leadership Role Director - Center for Drug Evaluation and …
For Immediate Release: February 26, 2019 Statement From: Statement Author Leadership Role Leadership Role Commissioner of Food and Drugs - Food and Drug Administration Scott Gottlieb M.D. Leadership Role Leadership Role Director - Center for Drug …
For Immediate Release: November 08, 2018 Statement From: Statement Author Leadership Role Leadership Role Commissioner of Food and Drugs - Food and Drug Administration Scott Gottlieb M.D. Leadership Role Leadership Role Director - Center for Drug …
For Immediate Release: April 30, 2019 The U.S. Food and Drug Administration today announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to better ensure patients and their …
For Immediate Release: April 30, 2019 Statement From: Statement Author Leadership Role Leadership Role Commissioner of Food and Drugs - Food and Drug Administration Norman E. "Ned" Sharpless MD Leadership Role Leadership Role Deputy Commissioner …
© 1995-2019 IPD Group, Inc. dba EIN Presswire | EIN News. All Right Reserved.
|
User Agreement
|
Privacy Policy
|
Contact
